IN2014CN02870A - - Google Patents
Info
- Publication number
- IN2014CN02870A IN2014CN02870A IN2870CHN2014A IN2014CN02870A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A IN 2870CHN2014 A IN2870CHN2014 A IN 2870CHN2014A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A
- Authority
- IN
- India
- Prior art keywords
- proteins
- relates
- kits used
- diagnosis
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/34—Introducing sulfur atoms or sulfur-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1159348A FR2981352B1 (fr) | 2011-10-17 | 2011-10-17 | Procede de synthese de proteines |
| PCT/EP2012/070454 WO2013057084A1 (fr) | 2011-10-17 | 2012-10-16 | Procede de synthese de proteines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02870A true IN2014CN02870A (enExample) | 2015-07-03 |
Family
ID=47022687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2870CHN2014 IN2014CN02870A (enExample) | 2011-10-17 | 2012-10-16 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9206224B2 (enExample) |
| EP (1) | EP2768842B1 (enExample) |
| JP (1) | JP6321542B2 (enExample) |
| CN (1) | CN103998455B (enExample) |
| CA (1) | CA2852833A1 (enExample) |
| ES (1) | ES2702786T3 (enExample) |
| FR (1) | FR2981352B1 (enExample) |
| IN (1) | IN2014CN02870A (enExample) |
| SG (1) | SG11201401540WA (enExample) |
| WO (1) | WO2013057084A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2971509B1 (fr) * | 2011-02-16 | 2013-02-22 | Centre Nat Rech Scient | Procede de preparation de peptides par assemblage de multiples fragments peptidiques |
| AU2014286990A1 (en) | 2013-07-11 | 2016-02-11 | Novartis Ag | Lysine-specific chemoenzymatic protein modifications using microbial transglutaminase |
| NL2027769B1 (en) * | 2021-03-18 | 2022-09-29 | Univ Delft Tech | C-terminal peptide modification |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0832096T3 (da) | 1995-05-04 | 2001-10-01 | Scripps Research Inst | Syntese af proteiner ved nativ kemisk ligering |
| WO1998028434A1 (en) | 1996-12-24 | 1998-07-02 | The Scripps Research Institute | General chemical ligation |
| AU745094B2 (en) * | 1997-06-13 | 2002-03-14 | Gryphon Sciences | Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution |
| AU2001281463A1 (en) | 2000-03-16 | 2001-09-24 | The Regents Of The University Of California | Chemoselective ligation |
| AU2001261530B2 (en) | 2000-05-12 | 2006-11-09 | Wisconsin Alumni Research Foundation | Ligation method and reagents to form an amide bond |
| CA2466746A1 (en) | 2001-11-14 | 2003-05-22 | Geneprot, Inc. | Extended native chemical ligation of three or more peptide fragments |
| TW200637872A (en) * | 2004-10-26 | 2006-11-01 | Lonza Ag | Thiol group protection and cyclization in solid-phase peptide synthesis |
| JP5139085B2 (ja) * | 2005-02-11 | 2013-02-06 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 固相のオリゴ糖タグ付け：固定化糖質の操作技術 |
| US7667076B2 (en) | 2005-09-14 | 2010-02-23 | Regents Of The University Of California | Amide forming chemical ligation |
| FR2952058B1 (fr) * | 2009-10-29 | 2013-10-04 | Centre Nat Rech Scient | Procede de ligation native de polypeptides |
| EP2501711B1 (en) | 2009-11-16 | 2014-01-08 | Centre National De La Recherche Scientifique CNRS | Compounds and methods for purifying peptides produced by solid phase peptide synthesis |
-
2011
- 2011-10-17 FR FR1159348A patent/FR2981352B1/fr not_active Expired - Fee Related
-
2012
- 2012-10-16 SG SG11201401540WA patent/SG11201401540WA/en unknown
- 2012-10-16 ES ES12772951T patent/ES2702786T3/es active Active
- 2012-10-16 JP JP2014536201A patent/JP6321542B2/ja active Active
- 2012-10-16 IN IN2870CHN2014 patent/IN2014CN02870A/en unknown
- 2012-10-16 CA CA2852833A patent/CA2852833A1/fr not_active Abandoned
- 2012-10-16 EP EP12772951.5A patent/EP2768842B1/fr not_active Not-in-force
- 2012-10-16 CN CN201280062427.3A patent/CN103998455B/zh not_active Expired - Fee Related
- 2012-10-16 WO PCT/EP2012/070454 patent/WO2013057084A1/fr not_active Ceased
- 2012-10-16 US US14/352,155 patent/US9206224B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103998455B (zh) | 2018-05-29 |
| US9206224B2 (en) | 2015-12-08 |
| SG11201401540WA (en) | 2014-06-27 |
| EP2768842A1 (fr) | 2014-08-27 |
| WO2013057084A1 (fr) | 2013-04-25 |
| FR2981352B1 (fr) | 2015-07-03 |
| ES2702786T3 (es) | 2019-03-05 |
| EP2768842B1 (fr) | 2018-07-25 |
| FR2981352A1 (fr) | 2013-04-19 |
| JP2014532075A (ja) | 2014-12-04 |
| CA2852833A1 (fr) | 2013-04-25 |
| US20140256879A1 (en) | 2014-09-11 |
| JP6321542B2 (ja) | 2018-05-09 |
| CN103998455A (zh) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120390T1 (el) | Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων | |
| TN2017000552A1 (en) | Antibody constructs for msln and cd3. | |
| MX355416B (es) | Biomarcadores de cancer de pulmon y usos de los mismos. | |
| WO2014124334A3 (en) | Transthyretin antibodies and uses thereof | |
| MY161291A (en) | Antibody, kit and method for determination of amyloid peptides | |
| EP4282484A3 (en) | Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases | |
| MX2018009304A (es) | Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. | |
| NZ700823A (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| EA201790438A1 (ru) | Антигенсвязывающие белки, которые связываются с cxcr5 | |
| EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
| HK1206425A1 (en) | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration | |
| EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
| BR112013024213B8 (pt) | Método de fabricação de instrumento médico e instrumento médico | |
| MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
| MX2016000393A (es) | Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana. | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| WO2016023991A8 (de) | Verfahren zur mikrobiom-analyse | |
| WO2014091490A3 (en) | Diagnosis of autoimmune diseases using a specific antibody profile | |
| IN2014CN02870A (enExample) | ||
| SG10201907690TA (en) | Device and method for detecting target molecules | |
| EP3112867A4 (en) | Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit | |
| WO2015013455A3 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| MY192159A (en) | Method for detecting neutralizing antibodies against recombinant human insulin in human serum | |
| MX2015009726A (es) | Metodo para la prediccion de la aparicion de sintomas extrapiramidales (sep) inducidos por un tratamiento con antipsicoticos. | |
| EP2924124A4 (en) | METHOD FOR DIAGNOSIS AND / OR FORECASTING NEURODEEGENERATIVE DISEASES |